Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoprofen Cataplasm for Pain in Knee Osteoarthritis
CTR20230456Phase 3Completed
- Sponsor
- Nanjing Haina Pharmaceutical Technology
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketoprofen in knee osteoarthritis (OA), knee arthralgia, sponsored by Nanjing Haina Pharmaceutical Technology. Started Feb 2023; status: completed.
02
Drugs
ketoprofen
03
Conditions
knee osteoarthritis (OA)knee arthralgia
Beyond the preview
Go deeper on CTR20230456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230456.